RxDoctor Payments Data

Rovnat Babazade, MD

Anesthesiology · Galveston, TXNPI 1861858458

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (35.7%), education and consulting fees — rather than concentrated in one kind of arrangement. 5 manufacturers reported payments, led by BD at 37.0% of the total. Among anesthesiology clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$3,646in general payments, 2019–2025

Across 8 payments — averaging $455.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • BD$1K
  • Milestone Scientific Inc.$1K
  • Edwards Lifesciences$850
  • GE HealthCare$190
  • Heron Therapeutics, Inc.$56
$82,347in research payments, 2019–2025

Across 12 payments — averaging $6862.25 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Pacira Pharmaceuticals Incorporated$82K

What the payments were for

  • Consulting fees$1,09030%
  • Speaking & faculty fees$1,30036%
  • Food & beverage$562%
  • Education$1,20033%

General payments by program year

19
22
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,646 in reported general payments places this provider in the 95th percentile of 3,899 anesthesiology providers in Texas.

See all anesthesiology providers in Texas

Medicare billing

Part B allowed, 2024
$10,184
Medicare patients
40
Services billed
45

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other anesthesiology in Galveston

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →